Scarica l'app Stockscreener
8.13
3.57%
0.28
Dopo l'orario di chiusura:
8.00
-0.13
-1.60%
Iteos Therapeutics Inc Borsa (ITOS) Ultime notizie
Iteos Therapeutics stock hits 52-week low at $7.58 By Investing.com - Investing.com UK
Insider Buying: Matthew Gall Acquires 5,000 Shares of ITeos Ther - GuruFocus.com
iTeos Therapeutics CFO Matthew Gall acquires $38,635 in common stock By Investing.com - Investing.com UK
iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World
Equities Analysts Offer Predictions for ITOS FY2024 Earnings - Defense World
US Bancorp DE Has $123,000 Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Simply Wall St
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
HC Wainwright Reaffirms Buy Rating for iTeos Therapeutics (NASDAQ:ITOS) - MarketBeat
EcoR1 Capital, LLC Reduces Stake in ITeos Therapeutics Inc - GuruFocus.com
FY2024 EPS Forecast for iTeos Therapeutics Lifted by Analyst - MarketBeat
Iteos Therapeutics stock hits 52-week low at $8.39 - Investing.com
Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World
iTeos Therapeutics Reports Q3 2024 Financial Results - TipRanks
iTeos verkündet Finanzergebnisse für das dritte Quartal 2024 und gibt aktuelle Geschäftsinformationen bekannt - GlobeNewswire Inc.
Creative Planning Acquires 1,196 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
iTeos Reports Wider Q3 Loss, Maintains $684M Cash Runway Through 2027 | ITOS Stock News - StockTitan
iTeos Therapeutics Inc. (ITOS) Quarterly 10-Q Report - Quartzy
Iteos Therapeutics stock hits 52-week low at $8.49 - Investing.com India
Iteos Therapeutics stock hits 52-week low at $8.49 By Investing.com - Investing.com South Africa
iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress - GlobeNewswire
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by nVerses Capital LLC - Defense World
Iteos Therapeutics stock hits 52-week low at $8.73 - Investing.com India
Iteos Therapeutics stock hits 52-week low at $8.73 By Investing.com - Investing.com Canada
Exchange Traded Concepts LLC Sells 6,414 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
(ITOS) Proactive Strategies - Stock Traders Daily
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Position Decreased by AQR Capital Management LLC - MarketBeat
BOXER CAPITAL, LLC Expands Stake in ITeos Therapeutics Inc - GuruFocus.com
ITeos Therapeutics Inc (ITOS) shows promising results - US Post News
Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 9.73, Down by -2.21 - The Dwinnex
ITOS Stock on the Rise: A Promising Investment - The InvestChronicle
Millennium Management LLC Decreases Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Millennium Management LLC Lowers Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Short Interest Update - Defense World
Squarepoint Ops LLC Sells 38,801 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
When (ITOS) Moves Investors should Listen - Stock Traders Daily
Did ITeos Therapeutics Inc (ITOS) perform well in the last session? - US Post News
Ratio Revelations: ITeos Therapeutics Inc (ITOS)’s Financial Metrics in the Spotlight - The Dwinnex
TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO - BioSpace
Dimensional Fund Advisors LP Raises Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
ITeos TherapeuticsAssessing Breakthrough Therapies To Treat Cancer - RTTNews
A new trading data show ITeos Therapeutics Inc (ITOS) is showing positive returns. - SETE News
American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
A closer look at ITeos Therapeutics Inc (ITOS)’s stock price trends - US Post News
Financial Metrics Exploration: Understanding ITeos Therapeutics Inc (ITOS) Through Ratios - The Dwinnex
How the (ITOS) price action is used to our Advantage - Stock Traders Daily
TANG CAPITAL MANAGEMENT LLC Acquires New Stake in ITeos Therapeu - GuruFocus.com
156,894 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Clearline Capital LP - Defense World
Clearline Capital LP Invests $2.33 Million in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
There is no way ITeos Therapeutics Inc (ITOS) can keep these numbers up - SETE News
ESMO recap: Keeping TIGIT alive, Rybrevant & immunotherapy anniversary — a BioCentury podcast - BioCentury
ITeos Therapeutics Inc (ITOS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Renaissance Technologies LLC Sells 157,700 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Rhumbline Advisers - Defense World
Renaissance Technologies LLC Has $8.30 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
Analytical Lens: Exploring ITeos Therapeutics Inc (ITOS)’s Financial Story Through Ratios - The Dwinnex
The week in pharma: action, reaction and insight – week to September 2024 | Pharmaceutical | The Pharmaletter - The Pharma Letter
(ITOS) Investment Report - Stock Traders Daily
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):